There have been significant improvements in the detection and treatment of breast cancer in recent decades. However, there is still a need to develop more effective therapeutic techniques that are patient specific wit...There have been significant improvements in the detection and treatment of breast cancer in recent decades. However, there is still a need to develop more effective therapeutic techniques that are patient specific with reduced toxicity leading to further increases in patients' overall survival; the ongoing progress in understanding recurrence, resistant and spread also needs to be maintained. Better understanding of breast cancer pathology, molecular biology and progression as well as identification of some of the underlying factors involved in breast cancer tumourgenesis and metastasis has led to the identification of novel therapeutic targets. Over a number of years interest has risen in breast tumour kinase(Brk) also known as protein tyrosine kinase 6; the research field has grown and Brk has been described as a desirable therapeutic target in relation to tyrosine kinase inhibition as well as disruption of its kinase independent activity. This review will outline the current "state of play" with respect to targeted therapy for breast cancer, as well as discussing Brk's role in the processes underlying tumour development and metas-tasis and its potential as a therapeutic target in breast cancer.展开更多
The intra and extracellular pathways of hepatic injury by coronavirus disease 2019(COVID-19)are still being studied.Understanding them is important to treat this viral disease and other liver and biliary tract disorde...The intra and extracellular pathways of hepatic injury by coronavirus disease 2019(COVID-19)are still being studied.Understanding them is important to treat this viral disease and other liver and biliary tract disorders.Thus,this paper aims to present three hypotheses about liver injury caused by COVID-19:(1)The interactions between severe acute respiratory syndrome coronavirus 2 spike protein and membrane receptors in the hepatocyte;(2)The dysbiosis and"gutliver axis"disruption in patients with serious clinical presentations of COVID-19;and(3)The inflammatory response exacerbated through the production of interleukins such as interleukin-6.However,despite these new perspectives,the pathophysiological process of liver injury caused by COVID-19 is still complex and multifactorial.Thus,understanding all these variables is a challenge to science but also the key to propose individualized and effective patient therapies.展开更多
HIP-55(HPK1-interacting protein of 55 ku,又名DBNL,SH3P7,mAbp1)是一种与HPK-1相结合分子量为55 ku,由多个具有蛋白相互作用结构域构成的接头蛋白。其N端含有肌动蛋白结合结构域C端具有SH3结构域。HIP-55能够通过细胞内信号转导调控...HIP-55(HPK1-interacting protein of 55 ku,又名DBNL,SH3P7,mAbp1)是一种与HPK-1相结合分子量为55 ku,由多个具有蛋白相互作用结构域构成的接头蛋白。其N端含有肌动蛋白结合结构域C端具有SH3结构域。HIP-55能够通过细胞内信号转导调控细胞内吞、迁移、骨架重排等生物功能并且在多种疾病病理生理过程中发挥重要作用。该文将对HIP-55蛋白生物学功能及其胞内信号转导通路参与疾病病理过程分子机制进行综述。展开更多
文摘There have been significant improvements in the detection and treatment of breast cancer in recent decades. However, there is still a need to develop more effective therapeutic techniques that are patient specific with reduced toxicity leading to further increases in patients' overall survival; the ongoing progress in understanding recurrence, resistant and spread also needs to be maintained. Better understanding of breast cancer pathology, molecular biology and progression as well as identification of some of the underlying factors involved in breast cancer tumourgenesis and metastasis has led to the identification of novel therapeutic targets. Over a number of years interest has risen in breast tumour kinase(Brk) also known as protein tyrosine kinase 6; the research field has grown and Brk has been described as a desirable therapeutic target in relation to tyrosine kinase inhibition as well as disruption of its kinase independent activity. This review will outline the current "state of play" with respect to targeted therapy for breast cancer, as well as discussing Brk's role in the processes underlying tumour development and metas-tasis and its potential as a therapeutic target in breast cancer.
文摘The intra and extracellular pathways of hepatic injury by coronavirus disease 2019(COVID-19)are still being studied.Understanding them is important to treat this viral disease and other liver and biliary tract disorders.Thus,this paper aims to present three hypotheses about liver injury caused by COVID-19:(1)The interactions between severe acute respiratory syndrome coronavirus 2 spike protein and membrane receptors in the hepatocyte;(2)The dysbiosis and"gutliver axis"disruption in patients with serious clinical presentations of COVID-19;and(3)The inflammatory response exacerbated through the production of interleukins such as interleukin-6.However,despite these new perspectives,the pathophysiological process of liver injury caused by COVID-19 is still complex and multifactorial.Thus,understanding all these variables is a challenge to science but also the key to propose individualized and effective patient therapies.
文摘HIP-55(HPK1-interacting protein of 55 ku,又名DBNL,SH3P7,mAbp1)是一种与HPK-1相结合分子量为55 ku,由多个具有蛋白相互作用结构域构成的接头蛋白。其N端含有肌动蛋白结合结构域C端具有SH3结构域。HIP-55能够通过细胞内信号转导调控细胞内吞、迁移、骨架重排等生物功能并且在多种疾病病理生理过程中发挥重要作用。该文将对HIP-55蛋白生物学功能及其胞内信号转导通路参与疾病病理过程分子机制进行综述。
